BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 9 - The Innovation Act S. 1137 - The PATENT Act (The Protecting American Talent and Entrepreneurship Act) S. 632 - The STRONG Act (The Support Technology and Research for Our Nations Growth Act) H.R. 1832 - The Innovation Protection Act H.R. 2045 - The TROL Act (The Targeting Rogue and Opaque Letters Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA GABRIELLE BUCCILLI | — |
| JOSEPH V SCHWAN | — |
Budget/Appropriations BUD
Report language for Labor HHS AG-FDA Annual Appropriations Bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| CRYSTAL RILEY | — |
| JOSEPH V SCHWAN | — |
Trade (domestic/foreign) TRD
H.R. 1295 Trade Preferences Extension Act of 2015. Support opening international markets by supporting the Trade Promotion Authority and the Trans Pacific Partnership agreement. Trans-Pacific Partnership Agreement
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA GABRIELLE BUCCILLI | — |
| JOSEPH V SCHWAN | — |
Taxation/Internal Revenue Code TAX
H.Con.Res. 25 S.Con. Res. Budget Resolutions Innovation Promotion Act of 2015 discussion draft International Tax Reform HR 880, the American Research and Competitiveness Act, and S. 537, the COMPETE Act, as they relate to the R&D tax credit. HR 2510, to make permanent bonus depreciation. HR 1430, to make permanent the CFC look through rule. S. 1946, the Tax Relief Extension Act, as it relates to the R&D credit, bonus depreciation, and the CFC look-through rule. HR 160, the Protect Medical Innovation Act, and S. 149, the Medical Device Access and Innovation Act, as they relate to repeal of the medical device excise tax. Budget reconciliation legislation, as it relates to the repeal of the medical device tax. Issues related to corporate tax reform and the taxation of U.S. multinational corporations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA GABRIELLE BUCCILLI | — |
| JACK MANIKO | — |
| JOSEPH V SCHWAN | — |
Health Issues HCR
340B Drug Discount Program; FDA Regulatory Environment. Raise awareness with legislators about the benefits of home dialysis. Drug Shortage 21st Century Cures Legislation-Healthier Americas Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| CRYSTAL RILEY | — |
| BELA SASTRY New | — |
| JOSEPH V SCHWAN | — |
Medicare/Medicaid MMM
Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis. The Chronic Kidney Disease Improvement in Research and Treatment Act is S.598 and H.R.1130 H.R.2948 Medicare Tele-health Parity Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| JACK MANIKO | — |
| CRYSTAL RILEY | — |
| BELA SASTRY New | — |
| JOSEPH V SCHWAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.